Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma

British Journal of Surgery

Volumn 92, Issue 4, 2005, Pages 471-477

  Van Dijkum, E J M Nieveein ^a   Kuhlmann, K F D ^a   Terwee, C B ^a   Obertop, H ^a   De Haes, J C J M ^a   Gouma, D J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; FEMALE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; LAPAROTOMY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; OUTCOMES RESEARCH; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PATIENT SELECTION; PERIAMPULLARY CARCINOMA; PHYSICAL DISEASE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; VATER PAPILLA CARCINOMA;

COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17144380803     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4887     Document Type: Article

References (34)

1. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995; 181: 483-503.
2. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227: 821-831.
3. van Geenen RC, van Gulik TM, Offerhaus GJ, de Wit LT, Busch OR, Obertop H et al. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma; an update. Eur J Surg Oncol 2001; 27: 549-557.
4. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579.
5. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003; 237: 74-85.
6. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33.
7. Gouma DJ, van Geenen RCI, van Gulik TM, de Haan RJ, de Wit LT, Busch ORC et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000; 232: 786-795.
8. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-2127.
9. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223: 718-725.
10. Gouma DJ, van Dijkum EJ, van Geenen RC, van Gulik TM, Obertop H. Are there indications for palliative resection in pancreatic cancer? World J Surg 1999; 23: 954-959.
11. van Wagensveld BA, Coene PP, van Gulik TM, Rauws EA, Obertop H, Gouma DJ. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg 1997; 84: 1402-1406.
12. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230: 322-328.
13. Fraser SCA. Quality-of-life measurement in surgical practice. Br J Surg 1993; 80: 163-169.
14. Camilleri-Brennan J, Steele RJ. Measurement of quality of life in surgery. JR Coll Surg Edinb 1999; 44: 252-259.
15. McLeod RS, Taylor BR, O'Connor BI, Greenberg GR, Jeejeebhoy KN, Royall D et al. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995; 169: 179-185.
16. Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000; 231: 890-898.
17. Ohtsuka T, Yamaguchi K, Chijiiwa K, Kinukawa N, Tanaka M. Quality of life after pylorus-preserving pancreatoduodenectomy. Am J Surg 2001; 182: 230-236.
18. Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual Life Res 1994; 3: 339-352.
19. Nieveen van Dijkum EJ, Romijn MG, Terwee CB, de Wit LT, van der Meulen JH, Lameris HS et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 2003; 237: 66-73.
20. Obertop H, Pedrazzoli S. Current views on surgical treatment of pancreatic cancer. Dig Surg 1999; 16: 263-264.
21. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724-735.
22. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216-222.
23. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62: 1034-1038.
24. Van Dijkum EJ, Terwee CB, Oosterveld P, van der Meulen JH, Gouma DJ, de Haes JC. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma. Br J Surg 2000; 87: 110-115.
25. Sloan J. Asking the obvious questions regarding patient burden. J Clin Oncol 2002; 20: 4-6.
26. Morris JN, Suissa S, Sherwood S, Wright SM, Greer D. Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis 1986; 39: 47-62.
27. Morris JN, Sherwood S. Quality of life of cancer patients at different stages in the disease trajectory. J Chronic Dis 1987; 40: 545-556.
28. Karnofsky DA, Abelmann WH, Graver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma, with particular reference to bronchogenic carcinoma. Cancer 1948; 1: 634-656.
29. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993; 31: 141-154.
30. Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000; 88: 1781-1787.
31. Zieren HU, Zippel K, Zieren J, Muller JM. Quality of life after surgical treatment of gastric carcinoma. Eur J Surg 1998; 164: 119-125.
32. Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR et al. Revealing response shift in longitudinal research on fatigue - the use of the thentest approach. Acta Oncol 1999; 38: 709-718.
33. Van Heek NT, De Castro SM, van Eijck CH, van Geenen RC, Hesselink EJ, Breslau PJ et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003; 238: 894-902.
34. Taylor MC, McLeod RS, Langer B. Biliary stenting vs. bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl 2000; 6: 3h02-308.